Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts.

Yang XM, Liu Y, Cui L, Yang X, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV.

Cardiovasc Drugs Ther. 2013 Apr;27(2):109-15. doi: 10.1007/s10557-012-6436-7.

2.

Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.

Yang XM, Liu Y, Cui L, Yang X, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV.

J Cardiovasc Pharmacol Ther. 2013 May;18(3):251-62. doi: 10.1177/1074248412467692. Epub 2012 Dec 10.

3.

Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases.

Shakur Y, de Koning HP, Ke H, Kambayashi J, Seebeck T.

Handb Exp Pharmacol. 2011;(204):487-510. doi: 10.1007/978-3-642-17969-3_20. Review.

PMID:
21695653
4.

Phosphodiesterases as targets for intermittent claudication.

Liu Y, Shakur Y, Kambayashi J.

Handb Exp Pharmacol. 2011;(204):211-36. doi: 10.1007/978-3-642-17969-3_9. Review.

PMID:
21695642
5.

Thrombocytogenesis by megakaryocyte; Interpretation by protoplatelet hypothesis.

Kosaki G, Kambayashi J.

Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(5):254-73. Review.

6.

Aripiprazole protects cortical neurons from glutamate toxicity.

Koprivica V, Regardie K, Wolff C, Fernalld R, Murphy JJ, Kambayashi J, Kikuchi T, Jordan S.

Eur J Pharmacol. 2011 Jan 25;651(1-3):73-6. doi: 10.1016/j.ejphar.2010.10.064. Epub 2010 Nov 18.

PMID:
21093427
7.

Cilostazol increases tissue blood flow in contracting rabbit gastrocnemius muscle.

Fong M, Yoshitake M, Kambayashi J, Liu Y.

Circ J. 2010 Jan;74(1):181-7. Epub 2009 Dec 5.

8.

Involvement of an alternatively spliced mitochondrial oxodicarboxylate carrier in adipogenesis in 3T3-L1 cells.

Niimi M, Tao L, Lin SH, Yin J, Wu X, Fukui H, Kambayashi J, Ye J, Sun B.

J Biomed Sci. 2009 Oct 13;16:92. doi: 10.1186/1423-0127-16-92.

9.

Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning.

Yang XM, Liu Y, Liu Y, Tandon N, Kambayashi J, Downey JM, Cohen MV.

Basic Res Cardiol. 2010 Jan;105(1):119-28. doi: 10.1007/s00395-009-0050-2. Epub 2009 Aug 8.

PMID:
19669077
10.

Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito.

Yoshida S, Sudo T, Niimi M, Tao L, Sun B, Kambayashi J, Watanabe H, Luo E, Matsuoka H.

Blood. 2008 Feb 15;111(4):2007-14. Epub 2007 Dec 4.

PMID:
18056842
11.

Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice.

Sun B, Li H, Shakur Y, Hensley J, Hockman S, Kambayashi J, Manganiello VC, Liu Y.

Cell Signal. 2007 Aug;19(8):1765-71. Epub 2007 Apr 6.

PMID:
17482796
12.

The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.

Li H, Lockyer S, Concepcion A, Gong X, Takizawa H, Guertin M, Matsumoto Y, Kambayashi J, Tandon NN, Liu Y.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1199-205. Epub 2007 Feb 22.

PMID:
17322098
13.

In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.

Jordan S, Regardie K, Johnson JL, Chen R, Kambayashi J, McQuade R, Kitagawa H, Tadori Y, Kikuchi T.

J Psychopharmacol. 2007 Aug;21(6):620-7. Epub 2006 Nov 8.

PMID:
17092971
14.

Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.

Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):348-56. Epub 2006 Oct 27.

PMID:
17070976
15.

Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.

Matsumoto Y, Takizawa H, Nakama K, Gong X, Yamada Y, Tandon NN, Kambayashi J.

Thromb Haemost. 2006 Aug;96(2):167-75.

PMID:
16894460
16.

In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.

Jordan S, Chen R, Fernalld R, Johnson J, Regardie K, Kambayashi J, Tadori Y, Kitagawa H, Kikuchi T.

Eur J Pharmacol. 2006 Jul 1;540(1-3):53-6. Epub 2006 May 3.

PMID:
16730695
17.

Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.

Matsumoto Y, Takizawa H, Gong X, Le S, Lockyer S, Okuyama K, Tanaka M, Yoshitake M, Tandon NN, Kambayashi J.

Thromb Res. 2007;119(3):319-29. Epub 2006 Mar 6.

PMID:
16566959
18.

GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.

Lockyer S, Okuyama K, Begum S, Le S, Sun B, Watanabe T, Matsumoto Y, Yoshitake M, Kambayashi J, Tandon NN.

Thromb Res. 2006;118(3):371-80. Epub 2005 Sep 2.

PMID:
16139873
19.

Antiplatelet and antithrombotic activity of cilostazol is potentiated by dipyridamole in rabbits and dissociated from bleeding time prolongation.

Li H, Cone J, Fong M, Kambayashi J, Yoshitake M, Liu Y.

Cardiovasc Drugs Ther. 2005 Jan;19(1):41-8.

PMID:
15883755
20.

Single embryonic stem cell-derived embryoid bodies for gene screening.

Niimi M, Kim MY, Tao L, Liu H, Wu X, Kambayashi J, Yoshitake M, Sun B.

Biotechniques. 2005 Mar;38(3):349-50, 352. No abstract available.

21.
22.

Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.

Liu Y, Cone J, Le SN, Fong M, Tao L, Shoaf SE, Bricmont P, Czerwiec FS, Kambayashi J, Yoshitake M, Sun B.

J Cardiovasc Pharmacol. 2004 Aug;44(2):266-73.

PMID:
15243309
23.

Cilostazol as a unique antithrombotic agent.

Kambayashi J, Liu Y, Sun B, Shakur Y, Yoshitake M, Czerwiec F.

Curr Pharm Des. 2003;9(28):2289-302. Review.

PMID:
14529391
24.

Expression of glycoprotein VI in vascular endothelial cells.

Sun B, Tao L, Lin S, Calingasan NY, Li J, Tandon NN, Yoshitake M, Kambayashi J.

Platelets. 2003 Jun;14(4):225-32.

PMID:
12850831
25.

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.

Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C; Tolvaptan Investigators.

Circulation. 2003 Jun 3;107(21):2690-6. Epub 2003 May 12.

PMID:
12742979
26.

Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.

Shakur Y, Fong M, Hensley J, Cone J, Movsesian MA, Kambayashi J, Yoshitake M, Liu Y.

Cardiovasc Drugs Ther. 2002 Sep;16(5):417-27.

PMID:
12652111
27.

Expression of glycoprotein VI in vascular endothelial cells.

Sun B, Tao L, Lin S, Calingasan NY, Li J, Tandon NN, Yoshitake M, Kambayashi JI.

Platelets. 2003;14(4):225-232. doi: 10.1080/0953710031000118858.

PMID:
28447516
28.

New mechanism of action for cilostazol: interplay between adenosine and cilostazol in inhibiting platelet activation.

Sun B, Le SN, Lin S, Fong M, Guertin M, Liu Y, Tandon NN, Yoshitake M, Kambayashi J.

J Cardiovasc Pharmacol. 2002 Oct;40(4):577-85.

PMID:
12352320
29.

Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.

Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN.

Thromb Haemost. 2002 Apr;87(4):728-34.

PMID:
12008958
30.

Luminometric assay of platelet activation in 96-well microplate.

Sun B, Tandon NN, Yamamoto N, Yoshitake M, Kambayashi J.

Biotechniques. 2001 Nov;31(5):1174, 1176, 1178 passim.

31.

Platelets in nonresponders to epinephrine stimulation showed reduced response to ADP.

Nakahashi TK, Kambayashi J, Nakamura T, Le SN, Yoshitake M, Tandon NN, Sun B.

Thromb Res. 2001 Oct 15;104(2):127-35.

PMID:
11672756
32.

OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonist.

Sun B, Lockyer S, Li J, Chen R, Yoshitake M, Kambayashi JI.

J Pharmacol Exp Ther. 2001 Nov;299(2):652-8.

PMID:
11602678
33.

High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.

Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J.

Atherosclerosis. 2001 Oct;158(2):277-87.

PMID:
11583705
34.

Morphological differences between GPIb antibody-induced and shear stress-induced platelet aggregates.

Nomura S, Tandon NN, Nakamura T, Kambayashi J.

Haemostasis. 2000 Jul-Aug;30(4):174-88.

PMID:
11155036
35.

Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication.

Liu Y, Fong M, Cone J, Wang S, Yoshitake M, Kambayashi J.

J Cardiovasc Pharmacol. 2000 Sep;36(3):351-60.

PMID:
10975593
36.

Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation.

Nomura S, Nakamura T, Cone J, Tandon NN, Kambayashi J.

Cytometry. 2000 Jul 1;40(3):173-81.

PMID:
10878559
37.

Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor.

Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B.

FEBS Lett. 2000 Mar 24;470(2):113-7.

38.

Evaluation of the Clot Signature Analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin.

Igawa T, Kornhauser R, Cilla DD, King JO, Kambayashi J.

Clin Appl Thromb Hemost. 1999 Apr;5(2):117-21.

PMID:
10725992
39.

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

Kawasaki T, Ozeki Y, Igawa T, Kambayashi J.

Stroke. 2000 Mar;31(3):591-5.

PMID:
10700490
40.
41.

An anti-platelet agent, OPC-29030, inhibits translocation of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid production in human platelets.

Ozeki Y, Nagamura Y, Ito H, Unemi F, Kimura Y, Igawa T, Kambayashi Ji, Takahashi Y, Yoshimoto T.

Br J Pharmacol. 1999 Dec;128(8):1699-704.

42.

Interaction between GPIbalpha and FcgammaIIA receptor in human platelets.

Sun B, Li J, Kambayashi Ji.

Biochem Biophys Res Commun. 1999 Dec 9;266(1):24-7.

PMID:
10581159
43.

Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.

Orito K, Imaizumi T, Yoshida K, Fujiki H, Kishi M, Teramoto S, Tanaka M, Shimizu H, Tominaga M, Kimura Y, Kambayashi J, Mori T.

J Pharmacol Exp Ther. 1999 Nov;291(2):604-11.

PMID:
10525078
44.

Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells.

Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, Yoshitake M, Kambayashi J, Liu Y.

J Cardiovasc Pharmacol. 1999 Oct;34(4):497-504.

PMID:
10511123
45.

Two distinct HCO(-)(3)-dependent H(+) efflux pathways in human vascular endothelial cells.

Sun B, Vaughan-Jones RD, Kambayashi J.

Am J Physiol. 1999 Jul;277(1):H28-32. doi: 10.1152/ajpheart.1999.277.1.H28.

PMID:
10409178
46.

Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.

Lockyer S, Kambayashi J.

J Cardiovasc Pharmacol. 1999 May;33(5):718-25.

PMID:
10226858
47.
48.

A unique method of closure for an aortocaval fistula in association with a ruptured abdominal aortic aneurysm: report of a case.

Uemura Y, Okagawa K, Kawasaki T, Monden M, Kambayashi J, Morimoto F, Sugimoto H.

Surg Today. 1998;28(11):1213-6.

PMID:
9851638
49.

Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells.

Okahara K, Sun B, Kambayashi J.

Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1922-6.

PMID:
9848885
50.

A role for local calcium gradients upon hypoxic injury in human umbilical vein endothelial cells (HUVEC).

Ikeda M, Ariyoshi H, Sakon M, Kambayashi J, Yoshikawa N, Shinoki N, Kawasaki T, Monden M.

Cell Calcium. 1998 Jul;24(1):49-57.

PMID:
9793688

Supplemental Content

Loading ...
Support Center